Clinical trials
Recruiting Phase 1 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 25 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Memorial Sloan Kettering Cancer Center | 2 |
| Beijing Biotech | 1 |
| Deciphera Pharmaceuticals, LLC | 1 |
| Dren Bio | 1 |
| Duboce Biopharmaceuticals, Inc. | 1 |
| Emory University | 1 |
| Exelixis | 1 |
| Generate Biomedicines | 1 |
| Genmab | 1 |
| Huahui Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 25 |
| Carcinoma, Non-Small-Cell Lung | 10 |
| Squamous Cell Carcinoma of Head and Neck | 7 |
| Carcinoma, Renal Cell | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Endometrial Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Melanoma | 4 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.